Right to Try for Individualized Treatments Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 2
- Latest action
- Jun 8, 2026
What it does
The bill would amend the Federal Food, Drug, and Cosmetic Act to allow patients diagnosed with life-threatening diseases or severely debilitating illnesses to access investigational individualized medical treatments—such as therapies based on a patient’s unique genomic profile—when approved treatments have been exhausted or deemed unlikely to help. It defines eligible patients, requires physician certification and informed consent (including additional consent for individualized treatments), and permits manufacturers to make such treatments available through eligible health care facilities, though they are not required to do so. The bill also updates definitions and conforming provisions to…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.